BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  4 min read
• Press Releases

  Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  1 min read
• Press Releases

  Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  2 min read
• Press Releases

  Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  1 min read
• Press Releases

  Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)

  August 3, 2025

   · 

  13 min read
• Press Releases

  Sirona Biochem Update to Shareholders on Financial Status and Operations

  August 3, 2025

   · 

  3 min read
• Press Releases

  Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  1 min read
• Press Releases

  AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

  August 3, 2025

   · 

  7 min read
• Press Releases

  Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

  August 3, 2025

   · 

  2 min read
• Press Releases

  Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 1, 2025

  August 3, 2025

   · 

  1 min read